The FDA has become the first global regulator to approve UCB’s Rystiggo, a treatment for generalised myasthenia gravis that the company says is the only drug that can be used for two of the most ...

Johnson & Johnson's Imaavy has become the first FcRn blocker to be approved in the EU as a treatment for both adolescent and adult patients with generalised myasthenia gravis (gMG), taking on rivals ...

Graphene Manufacturing Group Ltd, a clean-technology company, engages in the manufacture of graphene powder and energy saving and energy storage solutions enabled by graphene in Australia. The company ...

Investment (either directly or in partnerships with other investors) in industrial property, which includes warehouses and data centres, and management services provided to the partnerships, including ...